Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Research (NRC) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for National Research (NRC) over the last 16 years, with Q3 2025 value amounting to $17.8 million.

  • National Research's Current Deferred Revenue rose 296.51% to $17.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.8 million, marking a year-over-year increase of 296.51%. This contributed to the annual value of $15.8 million for FY2024, which is 641.77% up from last year.
  • National Research's Current Deferred Revenue amounted to $17.8 million in Q3 2025, which was up 296.51% from $15.6 million recorded in Q2 2025.
  • In the past 5 years, National Research's Current Deferred Revenue registered a high of $17.8 million during Q3 2025, and its lowest value of $14.5 million during Q2 2024.
  • For the 5-year period, National Research's Current Deferred Revenue averaged around $16.2 million, with its median value being $15.9 million (2023).
  • Per our database at Business Quant, National Research's Current Deferred Revenue soared by 1044.59% in 2021 and then crashed by 1170.63% in 2022.
  • National Research's Current Deferred Revenue (Quarter) stood at $17.2 million in 2021, then dropped by 11.71% to $15.2 million in 2022, then dropped by 2.4% to $14.8 million in 2023, then increased by 6.42% to $15.8 million in 2024, then rose by 12.85% to $17.8 million in 2025.
  • Its Current Deferred Revenue stands at $17.8 million for Q3 2025, versus $15.6 million for Q2 2025 and $15.5 million for Q1 2025.